Boussicault, L., Alves, S., Lamazière, A., Planques, A., Heck, N., Moumné, L., . . . Betuing, S. (2016). CYP46A1, the rate-limiting enzyme for cholesterol degradation, is neuroprotective in Huntington’s disease. Brain.
Παραπομπή Chicago StyleBoussicault, Lydie, et al. "CYP46A1, the Rate-limiting Enzyme for Cholesterol Degradation, Is Neuroprotective in Huntington’s Disease." Brain 2016.
Παραπομπή MLABoussicault, Lydie, et al. "CYP46A1, the Rate-limiting Enzyme for Cholesterol Degradation, Is Neuroprotective in Huntington’s Disease." Brain 2016.
Πρόσοχή: Οι παραπομπές μπορεί να μην είναι 100% ακριβείς.